Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies

被引:165
|
作者
Fusar-Poli, Paolo [1 ]
Meyer-Lindenberg, Andreas [2 ]
机构
[1] Univ Pavia, Dept Hlth Sci, Sect Psychiat, I-27100 Pavia, Italy
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-6800 Mannheim, Germany
关键词
neuroimaging; PET; striatum; dopamine; schizophrenia; psychosis; antipsychotic; POSITRON-EMISSION-TOMOGRAPHY; SYNTHESIS CAPACITY; PREFRONTAL CORTEX; PRODROMAL SIGNS; BRAIN; PSYCHOSIS; RELEASE; NAIVE; DYSFUNCTION; PREDICTION;
D O I
10.1093/schbul/sbr180
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Alterations in striatal dopamine neurotransmission are central to the emergence of psychotic symptoms and to the mechanism of action of antipsychotics. Although the functional integrity of the presynaptic system can be assessed by measuring striatal dopamine synthesis capacity (DSC), no quantitative meta-analysis is available. Methods: Eleven striatal (caudate and putamen) [C-11/F-18]-DOPA positron emission tomography studies comparing 113 patients with schizophrenia and 131 healthy controls were included in a quantitative meta-analysis of DSC. Demographic, clinical, and methodological variables were extracted from each study or obtained from the authors and tested as covariates. Hedges' g was used as a measure of effect size in Comprehensive Meta-Analysis. Publication bias was assessed with funnel plots and Egger's intercept. Heterogeneity was addressed with the Q statistic and I-2 index. Results: Patients and controls were well matched in sociodemographic variables (P > .05). Quantitative evaluation of publication bias was nonsignificant (P = .276). Heterogeneity across study was modest in magnitude and statistically nonsignificant (Q = 19.19; P = .078; I-2 = 39.17). Patients with schizophrenia showed increased striatal DSC as compared with controls (Hedges' g = 0.867, CI 95% from 0.594 to 1.140, Z = 6.222, P < .001). The DSC schizophrenia/control ratio showed a relatively homogenous elevation of around 14% in schizophrenic patients as compared with controls. DSC elevation was regionally confirmed in both caudate and putamen. Controlling for potential confounders such as age, illness duration, gender, psychotic symptoms, and exposure to antipsychotics had no impact on the results. Sensitivity analysis confirmed robustness of meta-analytic findings. Conclusions: The present meta-analysis showed consistently increased striatal DSC in schizophrenia, with a 14% elevation in patients as compared with healthy controls.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [1] Striatal D2 dopamine receptor status in Parkinson's disease:: An [18F]dopa and [11C]raclopride PET study
    Dentresangle, C
    Veyre, L
    Le Bars, D
    Pierre, C
    Lavenne, F
    Pollak, P
    Guerin, J
    Froment, JC
    Brousolle, E
    MOVEMENT DISORDERS, 1999, 14 (06) : 1025 - 1030
  • [2] Dopaminergic dysfunction in patients with restless legs:: [18F]dopa and [11C]raclopride PET studies
    Turjanski, N
    Lees, AJ
    Brooks, DJ
    NEUROLOGY, 1998, 50 (04) : A391 - A391
  • [3] PRESYNAPTIC DOPAMINE FUNCTION IN SCHIZOPHRENIA - AN F-18 DOPA PET STUDY
    ELKASHEF, AM
    DOUDET, D
    COHEN, RM
    WYATT, RJ
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 82 - 82
  • [4] 18F-DOPA PET STUDY OF THE PRESYNAPTIC DOPAMINE FUNCTION IN SCHIZOPHRENIA
    ELKASHEF, A
    DOUDET, D
    COHEN, R
    WYATT, R
    BIOLOGICAL PSYCHIATRY, 1995, 37 (09) : 626 - 626
  • [5] Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part II: Metabolism studies
    Peyronneau, Marie-Anne
    Saba, Wadad
    Dolle, Frederic
    Goutal, Sebastien
    Coulon, Christine
    Bottlaender, Michel
    Valette, Heric
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (03) : 347 - 359
  • [6] Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies
    Saba, Wadad
    Peyronneau, Marie-Anne
    Dolle, Frederic
    Goutal, Sebastien
    Bottlaender, Michel
    Valette, Heric
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (02) : 227 - 233
  • [7] Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density
    Fusar-Poli, Paolo
    Meyer-Lindenberg, Andreas
    SCHIZOPHRENIA BULLETIN, 2013, 39 (01) : 22 - 32
  • [8] Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
    Euitae Kim
    Oliver D Howes
    Mattia Veronese
    Katherine Beck
    Seongho Seo
    Jin Woo Park
    Jae Sung Lee
    Yun-Sang Lee
    Jun Soo Kwon
    Neuropsychopharmacology, 2017, 42 : 941 - 950
  • [9] Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
    Kim, Euitae
    Howes, Oliver D.
    Veronese, Mattia
    Beck, Katherine
    Seo, Seongho
    Park, Jin Woo
    Lee, Jae Sung
    Lee, Yun-Sang
    Kwon, Jun Soo
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (04) : 941 - 950
  • [10] ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F] DOPA AND [11C] RACLOPRIDE PET STUDY
    Kim, Euitae
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S382 - S382